December 05, 2016 1:14 AM ET

Pharmaceuticals

Company Overview of InCarda Therapeutics, Inc.

Key Executives for InCarda Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Grace E. Colon Ph.D.No RelationshipsChief Executive Officer and President--
Gregory M. Marcus M.D., M.A.S., F.A.C.C., F.A.H.A., F.H.R.S.3 RelationshipsCo-Founder and Chief Medical Officer for Consulting--
John S. Patton Ph.D., MSc, MBA 31 RelationshipsCo-Founder and Executive Chairman68
Narsi Rangachari M. Pharm.No RelationshipsCo-Founder and Chief Operating Officer--
Carlos A. Schuler Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
View More Key Executives

InCarda Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John S. Patton Ph.D., MSc, MBA 31 RelationshipsDance BioPharm Inc.68
Raymond John Lipicky M.D. 53 RelationshipsInCarda Therapeutics, Inc.--
David R. Savello Ph.D. 38 RelationshipsPappas Capital, LLC70
Robert Hamlin DVM, Ph.D. 7 RelationshipsPhaseBio Pharmaceuticals, Inc.--
Chet Leach Ph.D., D.A.B.T. 7 RelationshipsIR Biosciences Holdings Inc.--
View All Board Members

InCarda Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
393.0K
Bonus
512.8K
Total Short Term Compensation
577.6K
Total Value of Options
13.6M
Compensation as of Fiscal Year
InCarda Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Benchmark Holdings plc Announces Appointment of Kevin Quinn as Non-Executive Director
November 25, 2016 7:00 AM ET
Adcock Ingram Appoints Claudia Manning as Non-Executive Director
November 25, 2016 5:41 AM ET
Gufic Biosciences Ltd. Approves Appointment of Gopal Daptari as an Additional Independent Director
November 25, 2016 2:56 AM ET
Sharon Bio-Medicine Ltd Appoints Deepali Bhatia as Company Secretary & Compliance Officer
November 23, 2016 9:42 PM ET
Kotra Industries Bhd Announces Retirement of P'ng Beng Hoe Jp as Independent and Non Executive Chairman of Audit Committee
November 23, 2016 7:36 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact InCarda Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.